SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-19-013355
Filing Date
2019-07-24
Accepted
2019-07-24 16:01:08
Documents
1
Period of Report
2019-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5837
  Complete submission text file 0001140361-19-013355.txt   7405
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-38978 | Film No.: 19970966
SIC: 2834 Pharmaceutical Preparations

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations